Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2015

Open Access 01-12-2015 | Research

Automatic interactive optimization for volumetric modulated arc therapy planning

Authors: Jim P Tol, Max Dahele, Jarkko Peltola, Janne Nord, Ben J Slotman, Wilko FAR Verbakel

Published in: Radiation Oncology | Issue 1/2015

Login to get access

Abstract

Background

Intensity modulated radiotherapy treatment planning for sites with many different organs-at-risk (OAR) is complex and labor-intensive, making it hard to obtain consistent plan quality. With the aim of addressing this, we developed a program (automatic interactive optimizer, AIO) designed to automate the manual interactive process for the Eclipse treatment planning system. We describe AIO and present initial evaluation data.

Methods

Our current institutional volumetric modulated arc therapy (RapidArc) planning approach for head and neck tumors places 3-4 adjustable OAR optimization objectives along the dose-volume histogram (DVH) curve that is displayed in the optimization window. AIO scans this window and uses color-coding to differentiate between the DVH-lines, allowing it to automatically adjust the location of the optimization objectives frequently and in a more consistent fashion. We compared RapidArc AIO plans (using 9 optimization objectives per OAR) with the clinical plans of 10 patients, and evaluated optimal AIO settings. AIO consistency was tested by replanning a single patient 5 times.

Results

Average V95&V107 of the boost planning target volume (PTV) and V95 of the elective PTV differed by ≤0.5%, while average elective PTV V107 improved by 1.5%. Averaged over all patients, AIO reduced mean doses to individual salivary structures by 0.9-1.6Gy and provided mean dose reductions of 5.6Gy and 3.9Gy to the composite swallowing structures and oral cavity, respectively. Re-running AIO five times, resulted in the aforementioned parameters differing by less than 3%.

Conclusions

Using the same planning strategy as manually optimized head and neck plans, AIO can automate the interactive Eclipse treatment planning process and deliver dosimetric improvements over existing clinical plans.
Literature
1.
Nelms BE, Robinson G, Markham J, Velasco K, Boyd S, Narayan S, et al. Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems. Pract Radiat Oncol. 2012;2:296–305.CrossRefPubMed
2.
Das IJ, Cheng C-W, Chopra KL, Mitra RK, Srivastava SP, Glatstein E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst. 2008;100:300–7.CrossRefPubMed
3.
Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg. 1999;53:271–5.PubMed
4.
Van der Laan HP, Gawryszuk A, Christianen MEMC, Steenbakkers RJHM, Korevaar EW, Chouvalova O, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction. Radiother Oncol. 2013;107:282–7.CrossRefPubMed
5.
Quan EM, Chang JY, Liao Z, Xia T, Yuan Z, Liu H, et al. Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy? Int J Radiat Oncol Biol Phys. 2012;84:e69–76.CrossRefPubMedCentralPubMed
6.
Wu B, Ricchetti F, Sanguineti G, Kazhdan M, Simari P, Jacques R, et al. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning. Int J Radiat Oncol Biol Phys. 2011;79:1241–7.CrossRefPubMed
7.
Wu B, Pang D, Simari P, Taylor R, Sanguineti G, McNutt T. Using overlap volume histogram and IMRT plan data to guide and automate VMAT planning: a head-and-neck case study. Med Phys. 2013;40:021714.CrossRefPubMed
8.
Zhu X, Ge Y, Li T, Thongphiew D, Yin F-F, Wu QJ. A planning quality evaluation tool for prostate adaptive IMRT based on machine learning. Med Phys. 2011;38:719.CrossRefPubMed
9.
Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys. 2012;39:7446–61.CrossRefPubMed
10.
Moore KL, Brame RS, Low DA, Mutic S. Experience-based quality control of clinical intensity-modulated radiotherapy planning. Int J Radiat Oncol Biol Phys. 2011;81:545–51.CrossRefPubMed
11.
Tol JP, Delaney AR, Dahele M, Slotman BJ, Verbakel WFAR. Evaluation of a knowledge-based planning solution for head and neck cancer. Int J Radiat Oncol. 2015;91:612–20.CrossRef
12.
Fogliata A, Belosi F, Clivio A, Navarria P, Nicolini G, Scorsetti M, et al. On the pre-clinical validation of a commercial model-based optimisation engine: Application to volumetric modulated arc therapy for patients with lung or prostate cancer. Radiother Oncol. 2014;113:385–91.CrossRefPubMed
13.
Fogliata A, Wang P-M, Belosi F, Clivio A, Nicolini G, Vanetti E, et al. Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer. Radiat Oncol. 2014;9:236.CrossRefPubMedCentralPubMed
14.
Breedveld S, Storchi PRM, Voet PWJ, Heijmen BJM. iCycle: Integrated, multicriterial beam angle, and profile optimization for generation of coplanar and noncoplanar IMRT plans. Med Phys. 2012;39:951–63.CrossRefPubMed
15.
Voet PWJ, Dirkx MLP, Breedveld S, Fransen D, Levendag PC, Heijmen BJM. Toward fully automated multicriterial plan generation: a prospective clinical study. Int J Radiat Oncol Biol Phys. 2013;85:866–72.CrossRefPubMed
16.
17.
Tol JP, Dahele M, Doornaert P, Slotman BJ, Verbakel WFAR. Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: An exponential trade-off with target volume dose homogeneity. Med Phys. 2014;41:021722.CrossRefPubMed
18.
19.
Thilmann C, Zabel A, Nill S, Rhein B, Hoess A, Haering P, et al. Intensity-modulated radiotherapy of the female breast. Med Dosim. 2002;27:79–90.CrossRefPubMed
20.
Vanetti E, Nicolini G, Nord J, Peltola J, Clivio A, Fogliata A, et al. On the role of the optimization algorithm of RapidArc(®) volumetric modulated arc therapy on plan quality and efficiency. Med Phys. 2011;38:5844–56.CrossRefPubMed
21.
Verbakel WFAR, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys. 2009;74:252–9.CrossRefPubMed
22.
Doornaert P, Verbakel WFAR, Bieker M, Slotman BJ, Senan S. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:429–35.CrossRefPubMed
23.
Doornaert P, Verbakel WFAR, Rietveld DHF, Slotman BJ, Senan S. Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy. Radiat Oncol. 2011;6:74.CrossRefPubMedCentralPubMed
24.
Christianen MEMC, Schilstra C, Beetz I, Muijs CT, Chouvalova O, Burlage FR, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105:107–14.CrossRefPubMed
25.
Dijkema T, Raaijmakers CPJ, Ten Haken RK, Roesink JM, Braam PM, Houweling AC, et al. Parotid gland function after radiotherapy: the combined michigan and utrecht experience. Int J Radiat Oncol Biol Phys. 2010;78:449–53.CrossRefPubMedCentralPubMed
26.
Tol JP, Dahele M, Doornaert P, Slotman BJ, Verbakel WFAR. Different treatment planning protocols can lead to large differences in organ at risk sparing. Radiother Oncol. 2014;113:267–71.CrossRefPubMed
27.
Tol JP, Dahele M, Slotman BJ, Verbakel WFAR. Increasing the number of arcs improves head and neck volumetric modulated arc therapy plans. Acta Oncol. 2015;54:283–7.CrossRefPubMed
Metadata
Title
Automatic interactive optimization for volumetric modulated arc therapy planning
Authors
Jim P Tol
Max Dahele
Jarkko Peltola
Janne Nord
Ben J Slotman
Wilko FAR Verbakel
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2015
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-015-0388-6

Other articles of this Issue 1/2015

Radiation Oncology 1/2015 Go to the issue

Research

Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments

Research

Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution

Case report

Conservative management of a perianal rhabdomyosarcoma in a 2-year old child by Papillon’s technique

Research

A dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans

Research

Accuracy of inverse treatment planning on substitute CT images derived from MR data for brain lesions

Research

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison